loader

CONSORTIUM

HumanCellBio(Human Cell Bio)


img not found

About

title

HumanCellBio is a cell storage and cell therapy development company. It consists of a research team that has conducted research and development of cell therapy products that has been licensed from the Ministry of Food and Drug Administration. Based on the immuned cell culture technology characterized by NK cells and T cells, we are also developing a cell therapy agent that can boost cancer immunity.

HumanCellBio will become a leader in the bio-industry in Korea to lead in research and development and provide friendly services for everyone to enjoy a healthy and happy life.

HumanCellBio owns technology related to the development of about 5 billion immune cells, and is conducting Cell Banking (stem cell, immune cell) business. We plan to carry out anti-aging therapy (stem cell, immune cell) and Healthcare Membership project with HumanCellBio.

vision

title

We aim to become the best bio company that presents the global standard of life science. Through the world's best immune cell cultivation technology, we strive to become the leader of the bio industry in Korea that values social responsibility and human health.

  • Immune cell / stem cell storage
  • Development of immune cell therapy
  • MSO
  • Cell beauty / Anti-aging
  • Cosmeceutical
filter_img

Leeds Dream Medical Center

filter_img

Leeds Dream Medical Center

filter_img

Leeds Dream Medical Center

filter_img

Leeds Dream Medical Center

filter_img

Leeds Dream Medical Center

filter_img

Leeds Dream Medical Center

HUMANCELLBIO VIDEO

line

New paradigm of disease treatment, cell therapy

PlayPlay

Global Cancer Therapy Foundation and SBP


img not found

About

title

SBP is a company that deveoped SB anticancer drug, a new natural subtance extraction drug. We are currently conducting clinical trials at the Eastern and Western Medical Hospitals in Germany and Austria, and the results of the first clinical trial will be annoucned in Ocober 2018.

SB anticancer drugs have an excellent therapeutic effect not only in cancer but also in rheumatism, a new vascular disease. SB anticancer drugs are expected to greatly contribute to the expansion of the UNIGENE Global Clinic Network in Korea, China, and Southeast Asia. By having SB clinic in Europe as our central location, we plan to expand the global Clinic Network byexpanding the supply network of Cellgene's Cancer Diagnostic Kit.